Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 101–200 of 1,000
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
Rusu, V., Hoch, E., Mercader, J. M., Tenen, D. E., Gymrek, M., Hartigan, C. R., DeRan, M., von Grotthuss, M., Fontanillas, P., Spooner, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.011 · Cited by 152
“A precedent for this is illustrated by the efficacy of sulfonylureas in treating both individuals with neonatal diabetes who carry activating mutations in the sulfonylurea receptor complex as well as the general population of people with T2D (Gloyn et al., 2004; Inzucchi, 2002; Pearson et al., 2003).”
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Sim, X., Ong, R. T.-H., Suo, C., Tay, W.-T., Liu, J., Ng, D. P.-K., Boehnke, M., Chia, K.-S., Wong, T.-Y., Seielstad, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001363 · Cited by 152
“These genome-wide association studies (GWAS) have identified a number of novel loci harboring common variants that are associated with an increased risk of T2D [4–11], adding to the loci previously identified by candidate gene studies (PPARG [12], KCNJ11 [13–14], WFS1 [15–16]) and linkage studies TCF7L2 [17–19]).”
BackgroundElectrophysiology of Islet Cells
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-90-481-3271-3_7 · Cited by 152
Rubio-Cabezas, O., Patch, A.-M., Minton, J. A. L., Flanagan, S. E., Edghill, E. L., Hussain, K., Balafrej, A., Deeb, A., Buchanan, C. R., Jefferson, I. G., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1137 · Cited by 151
Self-citationWang, K., Dickson, S. P., Stolle, C. A., Krantz, I. D., Goldstein, D. B., & Hakonarson, H. H. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.003 · Cited by 172
“Many disease loci (for example, KCNJ11 for type 2 diabetes 54 ) were discovered through study of a few families with extreme or Mendelian form of the disease, whereas common variants with lower penetrance were later discovered at the same loci (for example, the E23K mutation in KCNJ11 has an OR…”
BackgroundMassa, O., Iafusco, D., D'Amato, E., Gloyn, A. L., Hattersley, A. T., Pasquino, B., Tonini, G., Dammacco, F., Zanette, G., Meschi, F., et al. (2005) · Human Mutation · doi:10.1002/humu.20124 · Cited by 152
“2 activating mutations [Gloyn et al., 2004].”
BackgroundInfluentialSelf-citationQ&A: insulin secretion and type 2 diabetes: why do β-cells fail?
Cantley, J., & Ashcroft, F. M. (2015) · BMC Biology · doi:10.1186/s12915-015-0140-6 · Cited by 188
“This makes T2D distinct from the much rarer monogenic forms of diabetes, such as maturity onset diabetes of the young (MODY) and neonatal diabetes [44].”
Self-citationRETRACTED: Nicotinamide nucleotide transhydrogenase: A key role in insulin secretion
Freeman, H. C., Shimomura, K., Horner, E., Cox, R., & Ashcroft, F. M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.008 · Cited by 157
Self-citationRetractedRoles of KATP channels as metabolic sensors in acute metabolic changes
Miki, T., & Seino, S. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.019 · Cited by 173
Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia
Heitzmann, D., & Warth, R. (2008) · Physiological Reviews · doi:10.1152/physrev.00020.2007 · Cited by 177
Genetics of type 2 diabetes mellitus
Malecki, M. T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.003 · Cited by 175
Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea
Seino, S. (2012) · Diabetologia · doi:10.1007/s00125-012-2562-9 · Cited by 172
Metabolic Regulation of the Pancreatic Beta-Cell ATP-Sensitive K+ Channel
Tarasov, A., Dusonchet, J., & Ashcroft, F. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s113 · Cited by 148
Self-citationThe emerging genetics of type 2 diabetes
Bonnefond, A., Froguel, P., & Vaxillaire, M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.06.004 · Cited by 174
Franco, E. D., Shaw-Smith, C. J., Flanagan, S. E., Shepherd, M. H., Hattersley, A. T., & Ellard, S. (2012) · Diabetes · doi:10.2337/db12-0885 · Cited by 159
Self-citationMinimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births
The Early Diabetes Study Group of ISPED, Iafusco, D., Massa, O., Pasquino, B., Colombo, C., Iughetti, L., Bizzarri, C., Mammì, C., Presti, D. L., Suprani, T., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0331-8 · Cited by 145
The missing link between genetic association and regulatory function
Connally, N. J., Nazeen, S., Lee, D., Shi, H., Stamatoyannopoulos, J., Chun, S., Cotsapas, C., Cassa, C. A., & Sunyaev, S. R. (2022) · eLife · doi:10.7554/elife.74970 · Cited by 158
Genetic Prediction of Future Type 2 Diabetes
Lyssenko, V., Almgren, P., Anevski, D., Orho-Melander, M., Sjögren, M., Saloranta, C., Tuomi, T., Groop, L., & the Botnia Study Group (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020345 · Cited by 145
“KCNJ11 Genetic variants in the KCNJ11 gene have not only been associated with T2D [16,18], but also with a severe form of neonatal diabetes [42].”
Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes
Flannick, J. A., Johansson, S., & Njølstad, P. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.50 · Cited by 168
Self-citationGenetic dissection of type 2 diabetes
Ridderstråle, M., & Groop, L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.002 · Cited by 155
“In addition, an activating mutation in the gene causes a severe form of neonatal diabetes (24).”
BackgroundATP‐Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles
Tinker, A., Aziz, Q. H., Li, Y., & Specterman, M. J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170048 · Cited by 150
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00217.x · Cited by 140
“The most severe defect is very marked developmental delay of motor and social function and generalized epilepsy often with hypsarrhythmia, as seen in West syndrome (C) (17).”
BackgroundSelf-citationClinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene
Støy, J., Steiner, D. F., Park, S. Y., Ye, H., Philipson, L. H., & Bell, G. I. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9151-3 · Cited by 150
“Neurological dysfunction is a key feature of the phenotype of some patients with PNDM due to mutations in KCNJ11 or ABCC8 [33–35].”
BackgroundBrook Chernet, M. L. (2014) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.s1-002 · Cited by 135
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes
Yang, Y., & Chan, L. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1116 · Cited by 152
Critical Role of Gap Junction Coupled KATP Channel Activity for Regulated Insulin Secretion
Rocheleau, J. V., Remedi, M. S., Granada, B., Head, W. S., Koster, J. C., Nichols, C. G., & Piston, D. W. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040026 · Cited by 132
Learning From Molecular Genetics
McCarthy, M. I., & Hattersley, A. T. (2008) · Diabetes · doi:10.2337/db08-0343 · Cited by 147
“2 channel that reduced channel closure in response to ATP led to the possibility of treating these patients with sulfonylureas that close the channel by an ATP-independent route (4,42).”
BackgroundSelf-citationInsights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics
Krentz, N. A. J., & Gloyn, A. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0325-0 · Cited by 139
Self-citationKullmann, D. M. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153122 · Cited by 128
“Mutations of two other inwardly rectifying potassium channel genes, KCNJ10 and KCNJ11, cause multisystem disorders that include epilepsy, ataxia, or muscle weakness among their manifestations (Bockenhauer et al. 2009, Gloyn et al. 2004, Proks et al. 2004).”
BackgroundSlingerland, A. S., Nuboer, R., Hadders‐Algra, M., Hattersley, A. T., & Bruining, G. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0407-0 · Cited by 129
“2 subunit of the potassium channel, as previously reported (case ISPAD 55) [1].”
BackgroundResultInfluentialSelf-citationDiagnosis and treatment of neonatal diabetes: an United States experience†
Støy, J., Greeley, S. A. W., Paz, V. P., Ye, H., Pastore, A. N., Skowron, K. B., Lipton, R. B., Cogen, F. R., Bell, G. I., Philipson, L. H., et al. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00433.x · Cited by 126
“Primers and PCR conditions have been described previously (6, 7, 19).”
MethodResultAt-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia
Hansen, T. F., Ingason, A., Djurovic, S., Melle, I. S., Fenger, M., Gústafsson, Ó., Jakobsen, K. D., Rasmussen, H. B., Tosato, S., Rietschel, M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.031 · Cited by 143
Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient
Peck, R. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052446 · Cited by 140
A Global Overview of Precision Medicine in Type 2 Diabetes
Fitipaldi, H., McCarthy, M. I., Florez, J. C., & Franks, P. W. (2018) · Diabetes · doi:10.2337/dbi17-0045 · Cited by 122
“These mutations block the closing of the KATP channels, which prevents b-cell depolarization and corresponding insulin secretion (57).”
BackgroundSlingerland, A. S., Shields, B. M., Flanagan, S. E., Bruining, G. J., Noordam, C., Gach, A., Mlynarski, W. M., Malecki, M. T., Hattersley, A. T., & Ellard, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1416-6 · Cited by 125
“In 2001 the Exeter Peninsula Molecular Genetics Laboratory based at the Royal Devon and Exeter Hospital (Exeter, UK) began recruiting patients worldwide prior to the discovery reported in 2004 that KCNJ11 mutations are the most common cause of PNDM [ 5 ].”
BackgroundSelf-citationHyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells
Brereton, M. F., Rohm, M., Shimomura, K., Holland, C., Tornovsky-Babeay, S., Dadon, D., Iberl, M., Chibalina, M. V., Lee, S., Glaser, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms13496 · Cited by 124
Self-citationEdghill, E. L., Dix, R. J., Flanagan, S. E., Bingley, P. J., Hattersley, A. T., Ellard, S., & Gillespie, K. M. (2006) · Diabetes · doi:10.2337/db06-0094 · Cited by 124
“This has been described with known monogenic causes of neonatal diabetes (19) such as heterozygous-activating KCNJ11 mutations (6) and homozygous glucokinase mutations (20).”
BackgroundSelf-citationPrevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry
Irgens, H. U., Molnes, J., Johansson, B. B., Ringdal, M., Skrivarhaug, T., Undlien, D. E., Søvik, O., Joner, G., Molven, A., & Njølstad, P. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2916-y · Cited by 136
“Mutations in the genes KCNJ11, ABCC8 and INS are most common in PNDM [3–5].”
BackgroundSelf-citationNew insights into KATP channel gene mutations and neonatal diabetes mellitus
Pipatpolkai, T., Usher, S., Stansfeld, P. J., & Ashcroft, F. M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0351-y · Cited by 122
Self-citationGenetic determinants of pubertal timing in the general population
Gajdos, Z. K. Z., Henderson, K. D., Hirschhorn, J. N., & Palmert, M. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.038 · Cited by 121
“In many instances, SNPs in the same genes that cause monogenic forms of a phenotype or disease have been associated with the corresponding common, complex trait, and it is possible that this could be the case for puberty as well [60–64].”
BackgroundType 2 Diabetes TCF7L2 Risk Genotypes Alter Birth Weight: A Study of 24,053 Individuals
Freathy, R. M., Weedon, M. N., Bennett, A. J., Hyppönen, E., Relton, C. L., Knight, B. A., Shields, B. M., Parnell, K. S., Groves, C. J., Ring, S. M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518517 · Cited by 137
Self-citationBonnefond, A., Durand, E., Sand, O., Graeve, F. D., Gallina, S., Busiah, K., Lobbens, S., Simon, A., Bellanné‐Chantelot, C., Létourneau, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013630 · Cited by 136
“The most striking example is seen for NDM patients with a mutation in the KATP channel genes, who can be treated effectively with oral sulfonylureas that directly bind the SUR1 regulatory subunit of the channel, rather than requiring life-long insulin therapy which usually provides poor glycemic contol [4,5,6].”
BackgroundATP-sensitive potassium channels: metabolic sensing and cardioprotection
Zingman, L. V., Alekseev, A. E., Hodgson-Zingman, D. M., & Terzic, A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00747.2007 · Cited by 122
Florez, J. C., Jablonski, K. A., Kahn, S. E., Franks, P. W., Dabelea, D., Hamman, R. F., Knowler, W. C., Nathan, D. M., Altshuler, D., & Groupy, F. T. D. P. P. R. (2007) · Diabetes · doi:10.2337/db06-0966 · Cited by 119
“Severe activating mutations in KCNJ11 cause a novel form of monogenic neonatal diabetes (1).”
BackgroundNew gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function
Perry, J. R., & Frayling, T. M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32830349a1 · Cited by 117
Self-citationYorifuji, T., Nagashima, K., Kurokawa, K., Kawai, M., Oishi, M., Akazawa, Y., Hosokawa, M., Yamada, Y., Inagaki, N., & Nakahata, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0096 · Cited by 121
Hattersley, A. T., & Pearson, E. R. (2006) · Endocrinology · doi:10.1210/en.2006-0152 · Cited by 120
“Excitingly, in initial physiological studies these patients had no insulin secretory response to glucose or glucagon, but did secrete insulin in response to tolbutamide (15).”
InfluentialSelf-citationRiddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T. (2020) · Diabetes Care · doi:10.2337/dci20-0065 · Cited by 117
Self-citationNeonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment
Greeley, S. A. W., Naylor, R. N., Philipson, L. H., & Bell, G. I. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0234-7 · Cited by 115
Genetic neurological channelopathies: molecular genetics and clinical phenotypes
Spillane, J. E., Kullmann, D. M., & Hanna, M. G. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311233 · Cited by 138
Mlynarski, W. M., Tarasov, A. I., Gach, A., Girard, C. A. J., Pietrzak, I., Zubcevic, L., Kuśmierek, J., Klupa, T., Malecki, M. T., & Ashcroft, F. M. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0640 · Cited by 116
Self-citationHamming, K. S. C., Soliman, D., Matemisz, L. C., Niazi, O., Lang, Y., Gloyn, A. L., & Light, P. E. (2009) · Diabetes · doi:10.2337/db09-0143 · Cited by 117
Self-citationLevin, M. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1236 · Cited by 120
Rubio-Cabezas, O., & Ellard, S. (2013) · Hormone Research in Paediatrics · doi:10.1159/000354219 · Cited by 115
Self-citationA novel mutation causing DEND syndrome: A treatable channelopathy of pancreas and brain
Shimomura, K., Hörster, F., de Wet, H., Flanagan, S. E., Ellard, S., Hattersley, A. T., Wolf, N. I., Ashcroft, F., & Ebinger, F. (2007) · Neurology · doi:10.1212/01.wnl.0000268488.51776.53 · Cited by 115
Self-citationPancreatic Development and Disease
Cano, D. A., Hebrok, M., & Zenker, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.054 · Cited by 141
Human KATP channelopathies: diseases of metabolic homeostasis
Olson, T. M., & Terzic, A. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0771-y · Cited by 112
“Gain-of-function mutations tend to keep channels open, hyperpolarize ß-cells, and reduce insulin secretion [41].”
BackgroundStanik, J., Gasperikova, D., Paskova, M., Barak, L., Javorkova, J., Jancova, E., Ciljakova, M., Hlava, P., Michalek, J., Flanagan, S. E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2490 · Cited by 112
“2 and ABCC8 coding the SUR1 subunit can lead to neonatal diabetes (13, 15, 16).”
BackgroundSelf-citationZeng, H., Guo, M., Zhou, T., Tan, L., Chong, C. N., Zhang, T., Dong, X., Xiang, J. Z., Yu, A. S., Yue, L., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.002 · Cited by 114
Busiah, K., Drunat, S., Vaivre‐Douret, L., Bonnefond, A., Simon, A., Flechtner, I., Gérard, B., Pouvreau, N., Elie, C., Nimri, R., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70059-7 · Cited by 118
A Shared Genetic Basis for Self-Limited Delayed Puberty and Idiopathic Hypogonadotropic Hypogonadism
Zhu, J., Choa, R. E.-Y., Guo, M. H., Plummer, L., Buck, C., Palmert, M. R., Hirschhorn, J. N., Seminara, S. B., & Chan, Y.-M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1080 · Cited by 114
Role of TREK-1 in Health and Disease, Focus on the Central Nervous System
Djillani, A., Mazella, J., Heurteaux, C., & Borsotto, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00379 · Cited by 124
“Mutations in this gene cause DEND syndrome, a very rare severe form of neonatal diabetes mellitus characterized by developmental delay, epilepsy and neonatal diabetes (Gloyn et al., 2004).”
BackgroundKATP channels and insulin secretion: a key role in health and disease
Ashcroft, F. M. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340243 · Cited by 111
Self-citationSulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation
Slingerland, A. S., Hurkx, W., Noordam, K., Flanagan, S. E., Jukema, J. W., Meiners, L. C., Bruining, G. J., Hattersley, A. T., & Hadders‐Algra, M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02373.x · Cited by 112
Self-citationPancreas islets in metabolic signaling - focus on the beta-cell
Suckale, J. (2008) · Frontiers in Bioscience · doi:10.2741/3218 · Cited by 110
“induced insulin secretion and lead to neonatal diabetes (56).”
BackgroundGloyn, A. L., Siddiqui, J., & Ellard, S. (2006) · Human Mutation · doi:10.1002/humu.20292 · Cited by 109
Self-citationATP-sensitive K + channels and disease: from molecule to malady
Ashcroft, F. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00348.2007 · Cited by 107
“2 mutations which cause neonatal diabetes lie within the putative ATP-binding site (3, 23, 50, 77, 82), which adds further strength to our argument that this region is involved in ATP binding.”
BackgroundInfluentialSelf-citationToward Linking Structure With Function in ATP-Sensitive K+ Channels
Bryan, J., Vila-Carriles, W. H., Zhao, G., Babenko, A. P., & Aguilar-Bryan, L. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s104 · Cited by 106
“2 associated with permanent neonatal diabetes (11).”
Mitchell, J. J., Punthakee, Z., Lo, B., Bernard, C., Chong, K., Newman, C., Cartier, L., Désilets, V. A., Cutz, E., Hansen, I. L., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1576-3 · Cited by 106
“2 subunit of the beta cell KATP channel have been identified in patients with permanent neonatal diabetes with or without dysmorphic features and neurological abnormalities [14].”
Neonatal Diabetes and the K ATP Channel: From Mutation to Therapy
Ashcroft, F. M., Puljung, M. C., & Vedovato, N. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.02.003 · Cited by 106
“2 mutation (G324R) that causes TNDM.”
InfluentialSelf-citationPrecision Medicine: A New Paradigm in Therapeutics
Akhoon, N. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_375_19 · Cited by 132
Yamada, S., Kane, G. C., Behfar, A., Liu, X., Dyer, R. B., Faustino, R. S., Miki, T., Seino, S., & Terzic, A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119511 · Cited by 113
“In particular, dysfunction in KATP channel gating has been linked with insulin secretory disorders, such as congenital hyperinsulinism and more recently neonatal diabetes (Thomas et al. 1995; Dunne et al. 2004; Gloyn et al. 2004; Ashcroft, 2005; Babenko et al. 2006; Pearson et al. 2006).”
BackgroundKoster, J. C., Cadario, F., Peruzzi, C., Colombo, C., Nichols, C. G., & Barbetti, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1826 · Cited by 106
Girard, C. A., Wunderlich, F. T., Shimomura, K., Collins, S., Kaizik, S., Proks, P., Abdulkader, F., Clark, A., Ball, V., Zubcevic, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35772 · Cited by 105
Self-citationNeuroprotective role of ATP-sensitive potassium channels in cerebral ischemia
Sun, H., & Feng, Z. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.138 · Cited by 116
A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome
Proks, P., Girard, C. A. J., Haider, S. M., Gloyn, A. L., Hattersley, A. T., Sansom, M. S. P., & Ashcroft, F. M. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400393 · Cited by 113
“The patient with this mutation had muscle weakness, generalized complex epilepsy, and motor and mental developmental delay that were so severe that she could not walk or speak at the age of 17 years (Gloyn et al, 2004).”
BackgroundInfluentialSelf-citationKane, G. C., Behfar, A., Dyer, R. B., O'Cochlain, D. F., Liu, X., Hodgson, D. M., Reyes, S., Miki, T., Seino, S., & Terzic, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl154 · Cited by 106
Habeb, A. M., Al-Magamsi, M. S., Eid, I. M., Ali, M. I., Hattersley, A. T., Hussain, K., & Ellard, S. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00828.x · Cited by 98
Self-citationBeltrand, J., Elie, C., Busiah, K., Fournier, E., Boddaert, N., Bahi-Buisson, N., Vera, M., Bui-Quoc, E., Ingster-Moati, I., Berdugo, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0837 · Cited by 98
Genetics and pathophysiology of neonatal diabetes mellitus
Naylor, R. N., Greeley, S. A. W., Bell, G. I., & Philipson, L. H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00106.x · Cited by 109
Pharmacogenetics of Anti-Diabetes Drugs
DiStefano, J. K., & Watanabe, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3082610 · Cited by 107
Modelling the endocrine pancreas in health and disease
Bakhti, M., Böttcher, A., & Lickert, H. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0132-z · Cited by 126
Klemen, M. S., Dolenšek, J., Rupnik, M. S., & Stožer, A. (2017) · Islets · doi:10.1080/19382014.2017.1342022 · Cited by 111
“Due to the critical role KATP channels play in insulin secretion, it is not surprising that polymorphisms in KATP subunits alter the biophysical properties of the channel and can lead to both hypo- and hyperglycemia.(67) In humans, KATP channel mutations that result in decreased KC currents cause persistent hyperinsul…”
BackgroundMonogenic Diabetes in Children and Adolescents: Recognition and Treatment Options
Sanyoura, M., Philipson, L. H., & Naylor, R. N. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1024-2 · Cited by 106
Beltrand, J., Busiah, K., Vaivre‐Douret, L., Fauret‐Amsellem, A., Berdugo, M., Cavé, H., & Polak, M. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.540718 · Cited by 113
Remedi, M. S., Kurata, H. T., Scott, A., Wunderlich, F. T., Rother, E., Kleinridders, A., Tong, A., Brüning, J. C., Koster, J. C., & Nichols, C. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.005 · Cited by 98
What controls the timing of puberty? An update on progress from genetic investigation
Gajdos, Z. K., Hirschhorn, J. N., & Palmert, M. R. (2009) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e328320253c · Cited by 96
Maitra, A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50029-8 · Cited by 104
Precision medicine in type 2 diabetes
Prasad, R. B., & Groop, L. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12859 · Cited by 91
Lahmann, C., Kramer, H. B., & Ashcroft, F. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134476 · Cited by 92
Self-citationATP and Sulfonylurea Sensitivity of Mutant ATP-Sensitive K+ Channels in Neonatal Diabetes
Koster, J. C., Remedi, M. S., Dao, C., & Nichols, C. G. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2645 · Cited by 96
“The mutation R201H causes a significant loss of ATP sensitivity (7), but it is predicted to be an ATPbinding site mutation (16,32,33) and thus may not show loss of SU sensitivity.”
BackgroundPatch, A. M., Flanagan, S. E., Boustred, C., Hattersley, A. T., & Ellard, S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00772.x · Cited by 92
Self-citationCauses of obesity: Looking beyond the hypothalamus
Peters, A., Pellerin, L., DALLMAN, M., Oltmanns, K. M., Schweiger, U., Born, J., & Fehm, H. L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.004 · Cited by 102
Shah, R. P., Spruyt, K., Kragie, B. C., Greeley, S. A. W., & Msall, M. E. (2012) · Diabetes Care · doi:10.2337/dc11-2225 · Cited by 94
“39), sex distribution (x [2] = 0.”
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T., Karges, B., Kordonouri, O., et al. (2016) · Diabetologie und Stoffwechsel · doi:10.1055/s-0042-111213 · Cited by 91
The endocrine pancreas: insights into development, differentiation, and diabetes
Mastracci, T. L., & Sussel, L. (2012) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.44 · Cited by 119
Yokoi, N., Kanamori, M., Horikawa, Y., Takeda, J., Sanke, T., Furuta, H., Nanjo, K., Mori, H., Kasuga, M., Hara, K., et al. (2006) · Diabetes · doi:10.2337/db05-1203 · Cited by 102
“Mutations in the genes (ABCC8 and KCNJ11) can cause familial persistent hyperinsulinemic hypoglycemia of infancy (5) and permanent neonatal diabetes (6).”
BackgroundGenomics of type 2 diabetes mellitus: implications for the clinician
Stolerman, E. S., & Florez, J. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.129 · Cited by 99
“In addition, activating mutations in KCNJ11 (an ATP-sensitive potassium channel that is involved in β-cell depolarization and insulin release) are associated with permanent neonatal diabetes”
BackgroundLevin, M., Pietak, A. M., & Bischof, J. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.04.003 · Cited by 82
Gloyn, A. L., Cummings, E. A., Edghill, E. L., Harries, L. W., Scott, R., Costa, T., Temple, I. K., Hattersley, A. T., & Ellard, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0568 · Cited by 90
Self-citation
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.